Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.3M | $4.2M | $384.6K | $793.6K | $1.2M | $473.6K | $1.3M | $1.2M |
| Cost of revenue | $553.3K | $214.6K | $143.7K | $285.7K | $336.1K | $517.3K | $460.7K | $486.3K |
| Gross profit | $699.0K | $4.0M | $240.9K | $507.9K | $870.0K | −$43.8K | $833.2K | $751.0K |
| Gross margin | 55.8% | 95.0% | 62.6% | 64.0% | 72.1% | -9.2% | 64.4% | 60.7% |
| R&D | $1.0M | $555.4K | $187.6K | $1.6M | $1.6M | $1.5M | $2.2M | $4.3M |
| Operating income | −$5.2M | $1.6M | −$3.4M | −$4.6M | −$3.1M | −$4.6M | −$4.8M | −$6.0M |
| EBITDA | −$4.6M | $1.5M | −$2.1M | −$3.0M | −$2.1M | −$3.2M | −$2.9M | −$5.9M |
| Net income | −$4.0M | $850.0K | −$2.6M | −$3.4M | −$2.3M | −$3.4M | −$3.1M | −$4.4M |
| Net margin | -318.8% | 20.1% | -685.1% | -430.4% | -194.2% | -725.8% | -241.3% | -356.8% |
| EPS (diluted) | -0.00 | 0.00 | -0.00 | -0.00 | -0.00 | -0.00 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
AVECHO BIOTECHNOLOGY LTD
No one on the platform currently holds AVEFF.
No tracked institution reports a position in AVEFF as of their last filing.
No one on the platform has traded AVEFF yet.
| $13M |
| — |
| LVCLYLiving Cell Technologies Limited | $0.03 | +24.39% | $11M | — |
| LXXGFLexaGene Holdings Inc. | $0.08 | +0.00% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.